Journal of Infection and Public Health

Papers
(The H4-Index of Journal of Infection and Public Health is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Isolation and characterizations of bacteriophages to treat multi-drug resistant bacterial infections936
Getting the counterfactual right: Estimating the cost per life saved of Covid-19 lockdown policies210
Brucellosis and associated risk factors, spatial distribution and cluster analysis: Case study in Khorasan Razavi Province, Iran207
Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase‐4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in perip206
QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions174
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study157
Rate of shed of SARS COV-2 viral RNA from COVID-19 cadavers116
Molecular epidemiology characteristics and detecting transmission of carbapenemase-producing enterobacterales in southwestern China98
Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination97
Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation87
Editorial Board87
Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months85
Relation between macrophage inflammatory protein-1 and intercellular adhesion molecule-1 and computed tomography findings in critically-ill saudi covid-19 patients85
Clinical pharmacy services in acute care setting during mass gatherings (Hajj): Insights from a task force80
Changes in the spatiotemporal patterns of COVID-19 in Japan from 2020 through 202376
Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan69
Epidemiological characterization and seasonality of respiratory syncytial virus in the United Arab Emirates: A five-year study at a tertiary care hospital, 2018–202269
Antimicrobial stewardship programs in acute-care hospitals: A multicenter assessment of structure, process, and outcome indicators in Italy and Spain68
Association between human leukocyte antigen alleles and COVID-19 disease severity61
Emergence of novel hypervirulent Acinetobacter baumannii strain and herpes simplex type 1 virus in a case of community-acquired pneumonia in China60
The direct application of plasma droplet digital PCR in the ultra-early pathogen detection and warning during sepsis: Case reports58
Time of developing surgical site infections and its association with patient and procedure characteristics54
Development and validation of artificial intelligence models to predict urinary tract infections and secondary bloodstream infections in adult patients52
The trends of mortality, aetiologies and risk factors of lower respiratory infections in China from 1990 to 2019: Findings from the Global Burden of Disease Study 201950
CTLA-4 rs5742909 but not ADAM33 rs2280091 is a predictor factor for COVID-19 mortality48
Effectiveness of COVID-19 vaccines against severe outcomes in cancer patients: Real-world evidence from self-controlled risk interval and retrospective cohort studies46
High prevalence of anti-Strongyloides antibody in SARS-CoV-2-infected human sera in a Thai hospital: Rapid serological screening45
Mortality in Norway and Sweden during the COVID-19 pandemic43
Cutaneous infection caused by Mycobacterium boenickei due to lipolysis injection: A case report42
Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes41
Association between respiratory pathogens and severe clinical outcomes in people living with HIV-1 and pulmonary infections: A 180-day longitudinal cohort study41
Lassa fever outbreak in West Africa: Rising regional cases with global implications41
Multidimensional challenges in Brazil's decision-making process of vaccines adoption: The case of childhood pneumococcal conjugate vaccines40
Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia38
Duration of mild acute SARS-CoV-2 infections with Omicron depending on previous vaccinations and infections – Using data of the German DigiHero cohort study from post-pandemic winters 2022/2023 and 2038
Applications of clear Dx whole genome sequencing system in SARS-CoV-2 diagnostics37
Assessing beneficial or side effects of COVID-vaccinations requires personal rather than electronic investigations36
Occupational class and risk of hepatitis B and C viral infections: A case-control study-based data from a nationwide hospital group in Japan36
0.077205896377563